PDCD1 and neoplasm: This behavior confirms our hypothesis from the previous model that combining OVT with anti-PD-1 treatment allows the antitumor immune response to reach its full potential; the strong innate response, combined with a strong adaptive immune response is sufficient to clear the tumor relatively quickly.